Radiotherapy Device - Global Market Outlook (2016-2022)
According to Stratistics MRC, the Global Radiotherapy Device market is accounted for $5.5 billion in 2015 and is expected to reach $9.1 billion by 2022 growing at a CAGR of 7.4% from 2015 to 2022. Radiotherapy being a painless treatment, increase in cancer patients and sophisticated diagnostic techniques are accelerating the market growth. The multiple side-effects of radiation therapy and shortage of trained personnel could hamper radiotherapy devices market growth. However, challenges in visualizing tumours will limit the radiotherapy device market growth.
External beam therapy is accounted for maximum share of the global radiotherapy market, followed by internal radiotherapy devices and systemic radiotherapy due to a high installation contracts for the Proton Therapy Device Segment. The prostate cancer application segment is expected to witness largest share in both external and internal radiotherapy market. North America is the largest market for radiotherapy devices followed by Europe. Asia-Pacific is expected to grow at the fastest rate during the forecast period due to improving healthcare infrastructure and favourable government activities.
Some of the key players in global Radiotherapy Device market are Accuray Incorporated, Coviden Plc., IBA Group, GE Healthcare, Elekta AB, IsoRay Medical, Inc., Nordion, Inc., RaySearch Laboratories AB, Mevion Medical Systems, Inc, Mitsubishi Electric Corporation, Protom International Inc, Siemens Healthcare, C.R. BARD, Inc. Angiodynamics Inc, Toshiba Medical Systems Corporation, Shenzhen GeneMDx Biotech. Co., Ltd., Varian Medical Systems, Inc., IntraOp Medical, Inc, Theragenics Corporation, Vision RT Ltd, Koninklijke Philips N.V, Eckert & Ziegler BEBIG, Oncura, Inc. and Sirtex Medical Ltd.
Products Covered:
External beam therapy is accounted for maximum share of the global radiotherapy market, followed by internal radiotherapy devices and systemic radiotherapy due to a high installation contracts for the Proton Therapy Device Segment. The prostate cancer application segment is expected to witness largest share in both external and internal radiotherapy market. North America is the largest market for radiotherapy devices followed by Europe. Asia-Pacific is expected to grow at the fastest rate during the forecast period due to improving healthcare infrastructure and favourable government activities.
Some of the key players in global Radiotherapy Device market are Accuray Incorporated, Coviden Plc., IBA Group, GE Healthcare, Elekta AB, IsoRay Medical, Inc., Nordion, Inc., RaySearch Laboratories AB, Mevion Medical Systems, Inc, Mitsubishi Electric Corporation, Protom International Inc, Siemens Healthcare, C.R. BARD, Inc. Angiodynamics Inc, Toshiba Medical Systems Corporation, Shenzhen GeneMDx Biotech. Co., Ltd., Varian Medical Systems, Inc., IntraOp Medical, Inc, Theragenics Corporation, Vision RT Ltd, Koninklijke Philips N.V, Eckert & Ziegler BEBIG, Oncura, Inc. and Sirtex Medical Ltd.
Products Covered:
- Internal Beam Radiotherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Electronic Brachytherapy
- Applicators & Afterloaders
- External Beam Radiation Therapy
- Intensity Modulated Radiotherapy (IMRT)
- Stereotactic Technology
- Proton Beam Therapy
- Image-Guided Radiotherapy (IGRT)
- 3D Conformal Radiotherapy (3D CRT)
- Tomotherapy
- Volumetric Modulated Arc Therapy (VMAT)
- Adaptive Radiation Therapy (ART)
- High-energy Linear Accelerators (LINACs)
- Gamma Knife
- CyberKnife
- Other External Therapy
- Systemic Radiation Therapy
- Iobenguane (I-131)
- Rhenium (Re-186)
- Samarium (Sm-153)
- Yttrium-90 (Y-90)
- Security and Access Control Clinics
- Ambulatory Surgical Centres
- Hospitals
- Brain cancer and Neurosurgery
- Gynecological Cancer
- Penile Cancer
- Esophageal Cancer
- Cervical Cancer
- Breast Cancer
- Prostate Cancer
- Spine Cancer
- Lung and pleura Cancers
- Colorectal Cancer
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.7 Emerging markets
3.8 Application Analysis
3.9 Product Analysis
3.10 End User Analysis
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL RADIOTHERAPY DEVICE MARKET, BY PRODUCT
5.1 Introduction
5.2 Internal Beam Radiotherapy
5.2.1 Cesium-131
5.2.2 Iodine-125
5.2.3 Palladium-103
5.2.4 Iridium-192
5.2.5 Electronic Brachytherapy
5.2.6 Applicators & Afterloaders
5.3 External Beam Radiation Therapy
5.3.1 Intensity Modulated Radiotherapy (IMRT)
5.3.2 Stereotactic Technology
5.3.3 Proton Beam Therapy
5.3.4 Image-Guided Radiotherapy (IGRT)
5.3.5 3D Conformal Radiotherapy (3D CRT)
5.3.6 Tomotherapy
5.3.7 Volumetric Modulated Arc Therapy (VMAT)
5.3.8 Adaptive Radiation Therapy (ART)
5.3.9 High-energy Linear Accelerators (LINACs)
5.3.10 Gamma Knife
5.3.11 CyberKnife
5.3.12 Other External Therapy
5.3.12.1 Intraoperative Radiation Therapy (IORT)
5.3.12.2 4-dimensional Radiotherapy (4D-RT)
5.3.12.3 Electron Beam Radiation Therapy
5.3.12.4 Neutron Beam Radiation Therapy
5.4 Systemic Radiation Therapy
5.4.1 Iobenguane (I-131)
5.4.2 Rhenium (Re-186)
5.4.3 Samarium (Sm-153)
5.4.4 Yttrium-90 (Y-90)
6 GLOBAL RADIOTHERAPY DEVICE MARKET, BY END USER
6.1 Introduction
6.2 Clinics
6.3 Ambulatory Surgical Centres
6.4 Hospitals
7 GLOBAL RADIOTHERAPY DEVICE MARKET, BY APPLICATION
7.1 Introduction
7.2 Brain cancer and Neurosurgery
7.3 Gynecological Cancer
7.4 Penile Cancer
7.5 Esophageal Cancer
7.6 Cervical Cancer
7.7 Breast Cancer
7.8 Prostate Cancer
7.9 Spine Cancer
7.10 Lung and pleura Cancers
7.11 Colorectal Cancer
8 GLOBAL RADIOTHERAPY DEVICE MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.8 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.8 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Accuray Incorporated
10.2 Coviden Plc.
10.3 IBA Group
10.4 GE Healthcare
10.5 Elekta AB
10.6 IsoRay Medical, Inc.
10.7 Nordion, Inc.
10.8 RaySearch Laboratories AB
10.9 Mevion Medical Systems, Inc
10.10 Mitsubishi Electric Corporation
10.11 Protom International Inc
10.12 Siemens Healthcare
10.13 C.R. BARD, Inc.
10.14 Angiodynamics Inc
10.15 Toshiba Medical Systems Corporation
10.16 Shenzhen GeneMDx Biotech. Co., Ltd.
10.17 Varian Medical Systems, Inc.
10.18 IntraOp Medical, Inc
10.11 Theragenics Corporation
10.20 Vision RT Ltd
10.21 Koninklijke Philips N.V
10.22 Eckert & Ziegler BEBIG
10.23 Oncura, Inc.
10.24 Sirtex Medical Ltd
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.7 Emerging markets
3.8 Application Analysis
3.9 Product Analysis
3.10 End User Analysis
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL RADIOTHERAPY DEVICE MARKET, BY PRODUCT
5.1 Introduction
5.2 Internal Beam Radiotherapy
5.2.1 Cesium-131
5.2.2 Iodine-125
5.2.3 Palladium-103
5.2.4 Iridium-192
5.2.5 Electronic Brachytherapy
5.2.6 Applicators & Afterloaders
5.3 External Beam Radiation Therapy
5.3.1 Intensity Modulated Radiotherapy (IMRT)
5.3.2 Stereotactic Technology
5.3.3 Proton Beam Therapy
5.3.4 Image-Guided Radiotherapy (IGRT)
5.3.5 3D Conformal Radiotherapy (3D CRT)
5.3.6 Tomotherapy
5.3.7 Volumetric Modulated Arc Therapy (VMAT)
5.3.8 Adaptive Radiation Therapy (ART)
5.3.9 High-energy Linear Accelerators (LINACs)
5.3.10 Gamma Knife
5.3.11 CyberKnife
5.3.12 Other External Therapy
5.3.12.1 Intraoperative Radiation Therapy (IORT)
5.3.12.2 4-dimensional Radiotherapy (4D-RT)
5.3.12.3 Electron Beam Radiation Therapy
5.3.12.4 Neutron Beam Radiation Therapy
5.4 Systemic Radiation Therapy
5.4.1 Iobenguane (I-131)
5.4.2 Rhenium (Re-186)
5.4.3 Samarium (Sm-153)
5.4.4 Yttrium-90 (Y-90)
6 GLOBAL RADIOTHERAPY DEVICE MARKET, BY END USER
6.1 Introduction
6.2 Clinics
6.3 Ambulatory Surgical Centres
6.4 Hospitals
7 GLOBAL RADIOTHERAPY DEVICE MARKET, BY APPLICATION
7.1 Introduction
7.2 Brain cancer and Neurosurgery
7.3 Gynecological Cancer
7.4 Penile Cancer
7.5 Esophageal Cancer
7.6 Cervical Cancer
7.7 Breast Cancer
7.8 Prostate Cancer
7.9 Spine Cancer
7.10 Lung and pleura Cancers
7.11 Colorectal Cancer
8 GLOBAL RADIOTHERAPY DEVICE MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.8 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.8 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Accuray Incorporated
10.2 Coviden Plc.
10.3 IBA Group
10.4 GE Healthcare
10.5 Elekta AB
10.6 IsoRay Medical, Inc.
10.7 Nordion, Inc.
10.8 RaySearch Laboratories AB
10.9 Mevion Medical Systems, Inc
10.10 Mitsubishi Electric Corporation
10.11 Protom International Inc
10.12 Siemens Healthcare
10.13 C.R. BARD, Inc.
10.14 Angiodynamics Inc
10.15 Toshiba Medical Systems Corporation
10.16 Shenzhen GeneMDx Biotech. Co., Ltd.
10.17 Varian Medical Systems, Inc.
10.18 IntraOp Medical, Inc
10.11 Theragenics Corporation
10.20 Vision RT Ltd
10.21 Koninklijke Philips N.V
10.22 Eckert & Ziegler BEBIG
10.23 Oncura, Inc.
10.24 Sirtex Medical Ltd
LIST OF TABLES
1 Global Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
2 Global Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
3 Global Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
4 Global Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
5 Global Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
6 Global Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
7 Global Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
8 Global Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
9 Global Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
10 Global Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
11 Global Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
12 Global Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
13 Global Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
14 Global Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
15 Global Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
16 Global Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
17 Global Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
18 Global Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
19 Global Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
20 Global Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
21 Global Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
22 Global Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
23 Global Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
24 Global Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
25 Global Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
26 Global Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
27 Global Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
28 Global Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
29 Global Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
30 Global Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
31 Global Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
32 Global Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
33 Global Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
34 Global Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
35 Global Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
36 Global Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
37 Global Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
38 Global Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
39 Global Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
40 Global Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
41 Global Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
42 North America Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
43 North America Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
44 North America Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
45 North America Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
46 North America Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
47 North America Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
48 North America Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
49 North America Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
50 North America Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
51 North America Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
52 North America Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
53 North America Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
54 North America Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
55 North America Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
56 North America Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
57 North America Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
58 North America Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
59 North America Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
60 North America Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
61 North America Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
62 North America Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
63 North America Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
64 North America Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
65 North America Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
66 North America Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
67 North America Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
68 North America Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
69 North America Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
70 North America Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
71 North America Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
72 North America Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
73 North America Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
74 North America Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
75 North America Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
76 North America Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
77 North America Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
78 North America Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
79 North America Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
80 North America Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
81 North America Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
82 North America Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
83 Europe Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
84 Europe Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
85 Europe Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
86 Europe Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
87 Europe Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
88 Europe Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
89 Europe Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
90 Europe Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
91 Europe Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
92 Europe Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
93 Europe Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
94 Europe Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
95 Europe Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
96 Europe Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
97 Europe Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
98 Europe Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
99 Europe Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
100 Europe Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
101 Europe Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
102 Europe Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
103 Europe Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
104 Europe Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
105 Europe Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
106 Europe Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
107 Europe Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
108 Europe Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
109 Europe Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
110 Europe Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
111 Europe Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
112 Europe Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
113 Europe Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
114 Europe Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
115 Europe Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
116 Europe Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
117 Europe Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
118 Europe Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
119 Europe Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
120 Europe Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
121 Europe Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
122 Europe Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
123 Europe Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
124 Asia Pacific Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
125 Asia Pacific Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
126 Asia Pacific Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
127 Asia Pacific Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
128 Asia Pacific Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
129 Asia Pacific Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
130 Asia Pacific Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
131 Asia Pacific Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
132 Asia Pacific Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
133 Asia Pacific Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
134 Asia Pacific Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
135 Asia Pacific Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
136 Asia Pacific Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
137 Asia Pacific Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
138 Asia Pacific Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
139 Asia Pacific Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
140 Asia Pacific Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
141 Asia Pacific Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
142 Asia Pacific Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
143 Asia Pacific Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
144 Asia Pacific Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
145 Asia Pacific Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
146 Asia Pacific Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
147 Asia Pacific Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
148 Asia Pacific Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
149 Asia Pacific Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
150 Asia Pacific Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
151 Asia Pacific Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
152 Asia Pacific Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
153 Asia Pacific Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
154 Asia Pacific Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
155 Asia Pacific Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
156 Asia Pacific Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
157 Asia Pacific Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
158 Asia Pacific Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
159 Asia Pacific Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
160 Asia Pacific Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
161 Asia Pacific Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
162 Asia Pacific Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
163 Asia Pacific Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
164 Asia Pacific Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
165 RoW Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
166 RoW Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
167 RoW Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
168 RoW Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
169 RoW Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
170 RoW Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
171 RoW Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
172 RoW Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
173 RoW Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
174 RoW Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
175 RoW Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
176 RoW Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
177 RoW Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
178 RoW Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
179 RoW Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
180 RoW Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
181 RoW Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
182 RoW Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
183 RoW Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
184 RoW Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
185 RoW Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
186 RoW Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
187 RoW Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
188 RoW Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
189 RoW Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
190 RoW Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
191 RoW Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
192 RoW Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
193 RoW Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
194 RoW Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
195 RoW Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
196 RoW Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
197 RoW Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
198 RoW Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
199 RoW Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
200 RoW Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
201 RoW Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
202 RoW Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
203 RoW Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
204 RoW Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
205 RoW Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
1 Global Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
2 Global Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
3 Global Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
4 Global Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
5 Global Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
6 Global Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
7 Global Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
8 Global Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
9 Global Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
10 Global Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
11 Global Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
12 Global Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
13 Global Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
14 Global Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
15 Global Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
16 Global Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
17 Global Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
18 Global Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
19 Global Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
20 Global Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
21 Global Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
22 Global Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
23 Global Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
24 Global Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
25 Global Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
26 Global Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
27 Global Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
28 Global Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
29 Global Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
30 Global Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
31 Global Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
32 Global Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
33 Global Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
34 Global Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
35 Global Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
36 Global Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
37 Global Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
38 Global Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
39 Global Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
40 Global Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
41 Global Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
42 North America Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
43 North America Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
44 North America Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
45 North America Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
46 North America Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
47 North America Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
48 North America Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
49 North America Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
50 North America Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
51 North America Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
52 North America Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
53 North America Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
54 North America Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
55 North America Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
56 North America Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
57 North America Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
58 North America Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
59 North America Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
60 North America Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
61 North America Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
62 North America Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
63 North America Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
64 North America Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
65 North America Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
66 North America Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
67 North America Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
68 North America Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
69 North America Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
70 North America Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
71 North America Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
72 North America Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
73 North America Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
74 North America Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
75 North America Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
76 North America Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
77 North America Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
78 North America Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
79 North America Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
80 North America Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
81 North America Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
82 North America Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
83 Europe Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
84 Europe Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
85 Europe Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
86 Europe Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
87 Europe Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
88 Europe Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
89 Europe Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
90 Europe Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
91 Europe Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
92 Europe Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
93 Europe Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
94 Europe Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
95 Europe Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
96 Europe Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
97 Europe Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
98 Europe Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
99 Europe Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
100 Europe Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
101 Europe Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
102 Europe Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
103 Europe Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
104 Europe Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
105 Europe Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
106 Europe Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
107 Europe Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
108 Europe Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
109 Europe Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
110 Europe Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
111 Europe Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
112 Europe Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
113 Europe Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
114 Europe Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
115 Europe Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
116 Europe Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
117 Europe Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
118 Europe Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
119 Europe Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
120 Europe Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
121 Europe Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
122 Europe Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
123 Europe Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
124 Asia Pacific Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
125 Asia Pacific Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
126 Asia Pacific Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
127 Asia Pacific Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
128 Asia Pacific Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
129 Asia Pacific Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
130 Asia Pacific Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
131 Asia Pacific Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
132 Asia Pacific Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
133 Asia Pacific Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
134 Asia Pacific Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
135 Asia Pacific Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
136 Asia Pacific Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
137 Asia Pacific Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
138 Asia Pacific Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
139 Asia Pacific Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
140 Asia Pacific Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
141 Asia Pacific Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
142 Asia Pacific Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
143 Asia Pacific Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
144 Asia Pacific Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
145 Asia Pacific Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
146 Asia Pacific Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
147 Asia Pacific Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
148 Asia Pacific Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
149 Asia Pacific Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
150 Asia Pacific Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
151 Asia Pacific Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
152 Asia Pacific Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
153 Asia Pacific Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
154 Asia Pacific Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
155 Asia Pacific Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
156 Asia Pacific Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
157 Asia Pacific Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
158 Asia Pacific Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
159 Asia Pacific Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
160 Asia Pacific Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
161 Asia Pacific Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
162 Asia Pacific Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
163 Asia Pacific Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
164 Asia Pacific Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
165 RoW Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
166 RoW Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
167 RoW Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
168 RoW Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
169 RoW Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
170 RoW Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
171 RoW Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
172 RoW Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
173 RoW Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
174 RoW Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
175 RoW Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
176 RoW Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
177 RoW Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
178 RoW Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
179 RoW Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
180 RoW Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
181 RoW Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
182 RoW Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
183 RoW Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
184 RoW Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
185 RoW Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
186 RoW Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
187 RoW Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
188 RoW Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
189 RoW Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
190 RoW Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
191 RoW Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
192 RoW Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
193 RoW Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
194 RoW Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
195 RoW Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
196 RoW Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
197 RoW Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
198 RoW Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
199 RoW Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
200 RoW Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
201 RoW Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
202 RoW Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
203 RoW Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
204 RoW Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
205 RoW Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
